GROW
Price
$2.63
Change
+$0.03 (+1.15%)
Updated
Oct 22 closing price
Capitalization
32.34M
20 days until earnings call
Intraday BUY SELL Signals
IVZ
Price
$28.78
Change
-$0.47 (-1.61%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
12.91B
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GROW vs IVZ

GROW vs IVZ Comparison Chart in %
View a ticker or compare two or three
VS
GROW vs. IVZ commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GROW is a Buy and IVZ is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GROW with price predictions
Oct 22, 2026

GROW in upward trend: price may jump up because it broke its lower Bollinger Band on October 19, 2026

GROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 36 cases where GROW's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where GROW advanced for three days, in 152 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GROW as a result. In 51 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 50%.

The Moving Average Convergence Divergence Histogram (MACD) for GROW turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

GROW moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

The Aroon Indicator for GROW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. GROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.717) is normal, around the industry mean (2.404). P/E Ratio (10.958) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.319). Dividend Yield (0.012) settles around the average of (0.272) among similar stocks. P/S Ratio (3.675) is also within normal values, averaging (15.798).

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GROW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

A.I.Advisor
a Summary for IVZ with price predictions
Oct 22, 2026

IVZ's RSI Indicator ascending out of oversold territory

The RSI Indicator for IVZ moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 28 of the 32 cases the stock moved higher. This puts the odds of a move higher at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 56 cases where IVZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in 227 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In 59 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

IVZ moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IVZ crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for IVZ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.296) is normal, around the industry mean (2.404). P/E Ratio (-43.657) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (1.319). Dividend Yield (0.029) settles around the average of (0.272) among similar stocks. P/S Ratio (1.981) is also within normal values, averaging (15.798).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
GROW vs IVZ: Fundamental Ratings
GROW
IVZ
OUTLOOK RATING
1..100
5463
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
8092
PRICE GROWTH RATING
1..100
6147
P/E GROWTH RATING
1..100
9499
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GROW's Valuation (70) in the Investment Managers industry is in the same range as IVZ (75). This means that GROW’s stock grew similarly to IVZ’s over the last 12 months.

IVZ's Profit vs Risk Rating (53) in the Investment Managers industry is somewhat better than the same rating for GROW (100). This means that IVZ’s stock grew somewhat faster than GROW’s over the last 12 months.

GROW's SMR Rating (80) in the Investment Managers industry is in the same range as IVZ (92). This means that GROW’s stock grew similarly to IVZ’s over the last 12 months.

IVZ's Price Growth Rating (47) in the Investment Managers industry is in the same range as GROW (61). This means that IVZ’s stock grew similarly to GROW’s over the last 12 months.

GROW's P/E Growth Rating (94) in the Investment Managers industry is in the same range as IVZ (99). This means that GROW’s stock grew similarly to IVZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GROWIVZ
RSI
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
49%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 14 days ago
62%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 9 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
62%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (GROW: $2.60 vs. IVZ: $28.79)
Brand notoriety: GROW and IVZ are both not notable
Both companies represent the Investment Managers industry
Current volume relative to the 65-day Moving Average: GROW: 75% vs. IVZ: 145%
Market capitalization -- GROW: $32.34M vs. IVZ: $12.91B
GROW [@Investment Managers] is valued at $32.34M. IVZ’s [@Investment Managers] market capitalization is $12.91B. The market cap for tickers in the [@Investment Managers] industry ranges from $1.57 to $178.04B. The average market capitalization across the [@Investment Managers] industry is $8.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GROW’s FA Score shows that 0 FA rating(s) are green while IVZ’s FA Score has 0 green FA rating(s).

  • GROW’s FA Score: 0 green, 5 red.
  • IVZ’s FA Score: 0 green, 5 red.
According to our system of comparison, IVZ is a better buy in the long-term than GROW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GROW’s TA Score shows that 4 TA indicator(s) are bullish while IVZ’s TA Score has 4 bullish TA indicator(s).

  • GROW’s TA Score: 4 bullish, 5 bearish.
  • IVZ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GROW is a better buy in the short-term than IVZ.

Price Growth

GROW (@Investment Managers) experienced а -5.11% price change this week, while IVZ (@Investment Managers) price change was -0.03% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.40%. For the same industry, the average monthly price growth was -5.36%, and the average quarterly price growth was -0.89%.

Reported Earning Dates

GROW is expected to report earnings on Nov 11, 2026.

IVZ is expected to report earnings on Oct 27, 2026.

Industries' Descriptions

@Investment Managers (-1.40% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

View a ticker or compare two or three
GROW
Daily Signal:
Gain/Loss:
IVZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GROW and

Correlation & Price change

A.I.dvisor tells us that GROW and NEWT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GROW and NEWT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GROW
1D Price
Change %
GROW100%
+1.15%
NEWT - GROW
31%
Poorly correlated
+3.94%
IVZ - GROW
30%
Poorly correlated
-1.57%
DBRG - GROW
29%
Poorly correlated
N/A
BUR - GROW
27%
Poorly correlated
+10.49%
PAX - GROW
26%
Poorly correlated
-0.08%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETSY90.823.59
+4.12%
Etsy Inc
GTY28.450.98
+3.57%
Getty Realty Corp
FBIOP16.67-0.10
-0.60%
Fortress Biotech
SPWR0.23N/A
-1.98%
SunPower Inc.
LAES1.55-0.09
-5.49%
SEALSQ Corp